These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 22782165)

  • 21. Interleukin 23 expression in pyoderma gangrenosum and targeted therapy with ustekinumab.
    Guenova E; Teske A; Fehrenbacher B; Hoerber S; Adamczyk A; Schaller M; Hoetzenecker W; Biedermann T
    Arch Dermatol; 2011 Oct; 147(10):1203-5. PubMed ID: 21680759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ustekinumab for peristomal pyoderma gangrenosum.
    Fahmy M; Ramamoorthy S; Hata T; Sandborn WJ
    Am J Gastroenterol; 2012 May; 107(5):794-5. PubMed ID: 22552250
    [No Abstract]   [Full Text] [Related]  

  • 23. Severely recalcitrant pyoderma gangrenosum successfully treated with ustekinumab.
    Goldminz AM; Botto NC; Gottlieb AB
    J Am Acad Dermatol; 2012 Nov; 67(5):e237-8. PubMed ID: 23062936
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of severe recalcitrant pyoderma gangrenosum with ustekinumab.
    Low ZM; Mar A
    Australas J Dermatol; 2018 May; 59(2):131-134. PubMed ID: 29205260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ustekinumab for pyoderma gangrenosum.
    Kluger N
    Arch Dermatol; 2012 May; 148(5):655; author reply 656. PubMed ID: 22782165
    [No Abstract]   [Full Text] [Related]  

  • 26. Pyoderma gangrenosum caused by secukinumab successfully treated with risankizumab: a case report and literature review.
    Orita A; Hoshina D; Hirosaki K
    Clin Exp Dermatol; 2022 Jul; 47(7):1372-1374. PubMed ID: 35298047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe recalcitrant pyoderma gangrenosum treated with infliximab.
    Kaur MR; Lewis HM
    Br J Dermatol; 2005 Sep; 153(3):689-91. PubMed ID: 16120178
    [No Abstract]   [Full Text] [Related]  

  • 28. Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review.
    Juillerat P; Christen-Zäch S; Troillet FX; Gallot-Lavallée S; Pannizzon RG; Michetti P
    Dermatology; 2007; 215(3):245-51. PubMed ID: 17823524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pyoderma gangrenosum associated with hidradenitis suppurativa: a case report and review of the literature].
    García-Rabasco AE; Esteve-Martínez A; Zaragoza-Ninet V; Sánchez-Carazo JL; Alegre-de-Miquel V
    Actas Dermosifiliogr; 2010 Oct; 101(8):717-21. PubMed ID: 20965015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyoderma gangrenosum in an infant: A case report and review of the literature.
    Crouse L; McShane D; Morrell DS; Wu EY
    Pediatr Dermatol; 2018 Sep; 35(5):e257-e261. PubMed ID: 29656404
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.